Brigham Buhler
๐ค SpeakerAppearances Over Time
Podcast Appearances
And the conversion's one thing, because that's trying to sell and place your product in a way and argue the medical necessity and benefits of that compound. But to grow a market is a whole nother thing, because think about it. This is where it gets really gray and jaded with these pharmaceutical companies.
And the conversion's one thing, because that's trying to sell and place your product in a way and argue the medical necessity and benefits of that compound. But to grow a market is a whole nother thing, because think about it. This is where it gets really gray and jaded with these pharmaceutical companies.
And the conversion's one thing, because that's trying to sell and place your product in a way and argue the medical necessity and benefits of that compound. But to grow a market is a whole nother thing, because think about it. This is where it gets really gray and jaded with these pharmaceutical companies.
They'll have you sign these contracts as a 20-year-old kid saying, I'm not going to off-label promote. I agree. I've been trained that I'm not going to talk about something that this drug isn't indicated for. Then they send you to dinners with thought leaders in your field that tell you all the areas they're using these drugs that aren't on the label. which would be off-label promotion.
They'll have you sign these contracts as a 20-year-old kid saying, I'm not going to off-label promote. I agree. I've been trained that I'm not going to talk about something that this drug isn't indicated for. Then they send you to dinners with thought leaders in your field that tell you all the areas they're using these drugs that aren't on the label. which would be off-label promotion.
They'll have you sign these contracts as a 20-year-old kid saying, I'm not going to off-label promote. I agree. I've been trained that I'm not going to talk about something that this drug isn't indicated for. Then they send you to dinners with thought leaders in your field that tell you all the areas they're using these drugs that aren't on the label. which would be off-label promotion.
And then you're tasked with growing a market share and immense pressures put on you to grow market share. And you're out at a dinner with one of your doctors and you go, well, man, do I bring up what that doctor told me about using this? And let me give you an example. Like there was a antipsychotic, a very niche drug, right? Antipsychotics are not meant to just be handed out like candy, right?
And then you're tasked with growing a market share and immense pressures put on you to grow market share. And you're out at a dinner with one of your doctors and you go, well, man, do I bring up what that doctor told me about using this? And let me give you an example. Like there was a antipsychotic, a very niche drug, right? Antipsychotics are not meant to just be handed out like candy, right?
And then you're tasked with growing a market share and immense pressures put on you to grow market share. And you're out at a dinner with one of your doctors and you go, well, man, do I bring up what that doctor told me about using this? And let me give you an example. Like there was a antipsychotic, a very niche drug, right? Antipsychotics are not meant to just be handed out like candy, right?
They would literally train the sales reps to go in and instead of focusing on this very niche patient population, you would try to grow it to a more average patient population. So example would be, you've talked about the mother that comes in, she's stressed, she's anxious, she's having a hard time sleeping.
They would literally train the sales reps to go in and instead of focusing on this very niche patient population, you would try to grow it to a more average patient population. So example would be, you've talked about the mother that comes in, she's stressed, she's anxious, she's having a hard time sleeping.
They would literally train the sales reps to go in and instead of focusing on this very niche patient population, you would try to grow it to a more average patient population. So example would be, you've talked about the mother that comes in, she's stressed, she's anxious, she's having a hard time sleeping.
That mom that maybe wakes up in the middle of the night and just starts cleaning the house because she can't sleep. Mm-hmm. that might be a manic patient. That might be a patient that this compound could help. But that is not a manic.
That mom that maybe wakes up in the middle of the night and just starts cleaning the house because she can't sleep. Mm-hmm. that might be a manic patient. That might be a patient that this compound could help. But that is not a manic.
That mom that maybe wakes up in the middle of the night and just starts cleaning the house because she can't sleep. Mm-hmm. that might be a manic patient. That might be a patient that this compound could help. But that is not a manic.
This is what the drug companies would try to teach a clinician and get a clinician to essentially over-prescribe a drug and prescribe it in patient demographics that don't make sense. We talk often about the opioid crisis. The opioid crisis was preceded by the Valium crisis, which was the same family, the Sacklers. And this is what's wild.
This is what the drug companies would try to teach a clinician and get a clinician to essentially over-prescribe a drug and prescribe it in patient demographics that don't make sense. We talk often about the opioid crisis. The opioid crisis was preceded by the Valium crisis, which was the same family, the Sacklers. And this is what's wild.
This is what the drug companies would try to teach a clinician and get a clinician to essentially over-prescribe a drug and prescribe it in patient demographics that don't make sense. We talk often about the opioid crisis. The opioid crisis was preceded by the Valium crisis, which was the same family, the Sacklers. And this is what's wild.
The Sacklers in the 60s, I think, and 70s began to promote Valium for women who had headaches. And they tried to target housewives.
The Sacklers in the 60s, I think, and 70s began to promote Valium for women who had headaches. And they tried to target housewives.